3rd Vaccine Global Congress
Join us in Asia for the 3rd Congress in the series
4-6 October 2009, Singapore

VACCINE CONGRESS MOVES TO SINGAPORE: Due to continued political unrest in Thailand the organizers of the 3rd Vaccine Global Congress have decided to move the congress to the Ritz Carlton Hotel in Singapore. The dates of the congress remain the same, 4-6 October 2009.

Invited Speakers

Joe Cohen, GlaxoSmithKline Biologicals, Belgium

Beth-Ann Coller, Hawaii Biotech, USA

Ron Dagan, Ben-Gurion University of the Negev, Israel

Debbie Drane, CSL Limited, Australia

Andrew Dunning, Sanofi Pasteur, France

Adolfo Garcia-Sastre, Mount Sinai School of Medicine, USA

Nathalie Garcon, GlaxoSmithKline Biologicals, Belgium

Bruno Guy, Sanofi Pasteur, France

Joachim Hombach, World Health Organization, Switzerland

Hong Jin, MedImmune, USA

Hiroshi Kiyono, University of Tokyo, Japan

Christoph Klade, Intercell AG, Austria

Jennelle Kyd, Central Queensland University, Australia

Yong Liu, National Center for AIDS/STD Control and Prevention, China

Ed Mocarski, MedImmune, USA

Peter Nara, Iowa State University, USA

Walt Orenstein, Gates Foundation, USA

Rino Rappuoli, Novartis Vaccine, Italy

Supachai Rerk-Ngarm, Ministry of Public Health, Thailand

Jerald C. Sadoff, Aeras Global TB Vaccine Foundation, USA

John Shiver, Merck & Co., USA

David Weiner, University of Pennsylvania, USA

Bruce Weniger, Centers for Disease Control and Prevention, USA

Henry Wilde, Chulalongkorn University, Thailand

Mansour Yaich, PATH, Immunization Solutions, USA

View presentation information

Call for papers - abstract submission deadline: 31 May 2009
The annual Vaccine Congress has become the forum for a state-of-the-art report on the latest progress in the development of vaccines for infectious and non-infectious diseases. Following successful meetings in Amsterdam in 2007 and Boston in 2008, the Vaccine Global Congress travels to Asia for the third congress in the series.

The congress programme will consist of invited lectures and presentations selected from submitted abstracts. Coverage includes:

  • Human vaccines, infectious diseases
  • Human vaccines, non-infectious diseases
  • Veterinary vaccines
  • Immunology / Animal models
  • Vectors / Adjuvants / Drug delivery
  • Production / Manufacturing / Safety
  • Regulatory / Societal / Legislation aspects

Attendance at this congress will enable to you to:

  • Access unique, high-quality content and gain a state-of-the-art report on the development of vaccines for infectious and non-infectious diseases
  • Learn from experts and opinion leaders in the field and meet with the editors of the journal Vaccine.
  • Network with an interdisciplinary group – including academics and researchers, regulatory and governmental agencies, charities, and health and industry professionals.

The 3rd Vaccine Congress is sponsored and hosted by Vaccine – the pre-eminent journal for those interested in vaccines and vaccination – in collaboration with the International Society for Vaccines.

Programme update
09 June:  Programme outline announced
The programme overview for the 3rd Vaccine Global Congress is now available. Presentations are arranged within nine plenary and three breakout sessions with dedicated time for the presentation of ...
More »
Programme update
03 June: New invited speakers announced
The following speakers join the invited speaker line up for the 3rd Vaccine Global Congress: Joe Cohen, GlaxoSmithKline Biologicals, Belgium; Ron Dagan, Ben-Gurion University of the Negev, USA; ...
More »
Vaccine 3rd Global Congress
The Sponsoring Journal
 
Vaccine is the pre-eminent journal for those interested in vaccines and vaccination. Relevant topics range from basic research through to applications, safety and legislation.